Innovations in
Cancer Research
Clinical trials for cancer patients
will begin in 2013
READ MORE »
About VLST
VLST is dedicated to advancing immunotherapy treatments for cancer
and autoimmune diseases.
READ MORE »
LATEST NEWS
VLST Corporation Announces In-Licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
READ MORE »